UA108926C2 - LibreOffice? [2,3-D] +" +" !+ - Google Patents

LibreOffice? [2,3-D] +" +" !+

Info

Publication number
UA108926C2
UA108926C2 UAA201311548A UAA201311548A UA108926C2 UA 108926 C2 UA108926 C2 UA 108926C2 UA A201311548 A UAA201311548 A UA A201311548A UA A201311548 A UAA201311548 A UA A201311548A UA 108926 C2 UA108926 C2 UA 108926C2
Authority
UA
Ukraine
Prior art keywords
libreofficekinase
pyrrolo
dependent inhibitors
inhibitors
dependent
Prior art date
Application number
UAA201311548A
Other languages
English (en)
Ukrainian (uk)
Inventor
Марк Дейвід Ендрюс
Шаранджіт Каур Баґал
Карл Річард Ґібсон
Кійоюкі Омото
Томас Рюкманз
Сара Елізабет Скерратт
Пол Ентоні Стаппл
Original Assignee
Пфайзер Лімітед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45937493&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA108926(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Пфайзер Лімітед filed Critical Пфайзер Лімітед
Publication of UA108926C2 publication Critical patent/UA108926C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Abstract

Настоящее изобретение касается соединений формулы (I) EMBED ISISServer и их фармацевтически приемлемых солей, где заместители являются такими, как описано в данном документе, их применения в медицине, в частности как Trk-антагонистов.
UAA201311548A 2011-04-05 2012-03-22 LibreOffice? [2,3-D] +" +" !+ UA108926C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161471758P 2011-04-05 2011-04-05
PCT/IB2012/051363 WO2012137089A1 (en) 2011-04-05 2012-03-22 Pyrrolo [2, 3 -d] pyrimidine derivatives as inhibitors of tropomyosin- related kinases

Publications (1)

Publication Number Publication Date
UA108926C2 true UA108926C2 (ru) 2015-06-25

Family

ID=45937493

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201311548A UA108926C2 (ru) 2011-04-05 2012-03-22 LibreOffice? [2,3-D] +" +" !+

Country Status (31)

Country Link
US (2) US8846698B2 (ru)
EP (1) EP2694509B1 (ru)
JP (1) JP5595616B2 (ru)
KR (1) KR20130133905A (ru)
CN (1) CN103534257A (ru)
AP (1) AP2013007159A0 (ru)
AR (1) AR085852A1 (ru)
AU (1) AU2012238369A1 (ru)
BR (1) BR112013025792A2 (ru)
CA (1) CA2832291C (ru)
CL (1) CL2013002821A1 (ru)
CO (1) CO6801740A2 (ru)
CR (1) CR20130470A (ru)
CU (1) CU20130129A7 (ru)
DO (1) DOP2013000221A (ru)
EA (1) EA201391239A1 (ru)
EC (1) ECSP13013009A (ru)
ES (1) ES2581848T3 (ru)
GE (1) GEP20156417B (ru)
GT (1) GT201300236A (ru)
IL (1) IL228590A0 (ru)
MA (1) MA35024B1 (ru)
MX (1) MX2013011612A (ru)
NI (1) NI201300103A (ru)
PE (1) PE20141050A1 (ru)
SG (1) SG193513A1 (ru)
TN (1) TN2013000394A1 (ru)
TW (1) TWI443101B (ru)
UA (1) UA108926C2 (ru)
UY (1) UY34004A (ru)
WO (1) WO2012137089A1 (ru)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015516435A (ja) * 2012-05-11 2015-06-11 アッヴィ・インコーポレイテッド Ｎａｍｐｔ阻害薬
CA2885247A1 (en) * 2012-10-04 2014-04-10 Pfizer Limited Tropomyosin-related kinase inhibitors
EP2912036A1 (en) 2012-10-04 2015-09-02 Pfizer Limited Pyrrolo[3,2-c]pyridine tropomyosin-related kinase inhibitors
WO2014053967A1 (en) 2012-10-04 2014-04-10 Pfizer Limited Pyrrolo[2,3-d]pyrimidine tropomyosin-related kinase inhibitors
JP6437452B2 (ja) 2013-01-14 2018-12-12 インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ Ｐｉｍキナーゼ阻害剤として有用な二環式芳香族カルボキサミド化合物
DK2945939T3 (da) 2013-01-15 2020-03-23 Incyte Holdings Corp Thiazolcarboxamider og pyridincarboxamidforbindelser anvendelige som pim-kinaseinhibitorer
US9447026B2 (en) 2013-03-14 2016-09-20 Kalyra Pharmaceuticals, Inc. Bicyclic analgesic compounds
JP2016169161A (ja) * 2013-07-19 2016-09-23 大日本住友製薬株式会社 新規イミダゾピリジン化合物
AR097431A1 (es) 2013-08-23 2016-03-16 Incyte Corp Compuestos de carboxamida de furo y tienopiridina útiles como inhibidores de quinasas pim
TWI663159B (zh) 2013-12-10 2019-06-21 美商健臻公司 原肌球蛋白相關之激酶（ｔｒｋ）抑制劑
CN105814013A (zh) 2013-12-12 2016-07-27 卡利拉制药公司 双环烷基化合物及合成
JP2016540811A (ja) 2013-12-20 2016-12-28 ファイザー・リミテッドＰｆｉｚｅｒ Ｌｉｍｉｔｅｄ Ｎ−アシルピペリジンエーテルトロポミオシン関連キナーゼ阻害剤
US9777020B2 (en) * 2014-01-24 2017-10-03 Abbvie Inc. Furo-3-carboxamide derivatives and methods of use
PT3102555T (pt) 2014-02-05 2021-06-04 VM Oncology LLC Composições de compostos e seus usos
KR102401840B1 (ko) 2014-03-07 2022-05-25 리커리엄 아이피 홀딩스, 엘엘씨 프로펠란 유도체 및 합성
WO2015143654A1 (en) * 2014-03-26 2015-10-01 Merck Sharp & Dohme Corp. TrkA KINASE INHIBITORS,COMPOSITIONS AND METHODS THEREOF
EP3140298A1 (en) * 2014-05-07 2017-03-15 Pfizer Inc. Tropomyosin-related kinase inhibitors
CN103992319B (zh) * 2014-05-27 2015-09-16 天津市斯芬克司药物研发有限公司 一种吡啶羧酸类化合物的制备方法
US9580418B2 (en) 2014-07-14 2017-02-28 Incyte Corporation Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
WO2016010897A1 (en) 2014-07-14 2016-01-21 Incyte Corporation Bicyclic heteroaromatic carboxamide compounds useful as pim kinase inhibitors
WO2016009296A1 (en) 2014-07-16 2016-01-21 Pfizer Inc. N-acylpiperidine ether tropomyosin-related kinase inhibitors
WO2016020784A1 (en) 2014-08-05 2016-02-11 Pfizer Inc. N-acylpyrrolidine ether tropomyosin-related kinase inhibitors
JP6833677B2 (ja) * 2014-09-17 2021-02-24 リキュリウム アイピー ホールディングス リミテッド ライアビリティー カンパニー 二環式化合物
CN107231803B (zh) 2014-12-18 2019-12-03 建新公司 原肌球蛋白相关激酶(trk)抑制剂的药物制剂
EP3239150B1 (en) * 2014-12-24 2020-02-05 Takeda Pharmaceutical Company Limited Heterocyclic compound
CN105837574B (zh) * 2015-02-02 2018-03-02 四川大学 N‑(3‑哌啶基)‑芳香胺衍生物及其制备方法和用途
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
WO2016196244A1 (en) 2015-05-29 2016-12-08 Incyte Corporation Pyridineamine compounds useful as pim kinase inhibitors
WO2017027883A1 (en) 2015-08-13 2017-02-16 San Diego State University Research Foundation Atropisomerism for increased kinase inhibitor selectivity
AR105967A1 (es) 2015-09-09 2017-11-29 Incyte Corp Sales de un inhibidor de pim quinasa
EP3350178B1 (en) 2015-09-14 2021-10-20 Pfizer Inc. Novel imidazo [4,5-c]quinoline and imidazo [4,5-c][1,5]naphthyridine derivatives as lrrk2 inhibitors
US9920032B2 (en) 2015-10-02 2018-03-20 Incyte Corporation Heterocyclic compounds useful as pim kinase inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
EP3475280B1 (en) * 2016-06-23 2020-04-08 H. Hoffnabb-La Roche Ag Novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives
CN107011347B (zh) * 2017-04-18 2019-01-18 华东师范大学 一种4-氯-7H-吡咯并[2,3-d]嘧啶的合成方法
MX2019013557A (es) 2017-05-15 2022-01-27 Recurium Ip Holdings Llc Compuestos biciclo[1.1.1]pentilo sustituidos y uso de los mismos para el tratamiento del dolor y fiebre.
US10934300B2 (en) 2017-06-23 2021-03-02 San Diego State University (Sdsu) Foundation Atropisomerism for enhanced kinase inhibitor selectivity
US10596161B2 (en) 2017-12-08 2020-03-24 Incyte Corporation Low dose combination therapy for treatment of myeloproliferative neoplasms
TW202003519A (zh) * 2018-03-28 2020-01-16 日商武田藥品工業股份有限公司 雜環化合物及其用途
CN109053575A (zh) * 2018-08-24 2018-12-21 遵义医学院 3-环丙基-1-甲基-1h-吡唑-4-甲醛的制备工艺
WO2020084389A1 (en) * 2018-10-23 2020-04-30 Lupin Limited Ribociclib intermediate and process for preparation thereof
WO2020188015A1 (en) 2019-03-21 2020-09-24 Onxeo A dbait molecule in combination with kinase inhibitor for the treatment of cancer
JP2021050161A (ja) 2019-09-25 2021-04-01 武田薬品工業株式会社 複素環化合物及びその用途
AU2020378630A1 (en) 2019-11-08 2022-05-26 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the treatment of cancers that have acquired resistance to kinase inhibitors
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use
AR122141A1 (es) 2020-05-28 2022-08-17 Lilly Co Eli Inhibidor de trka
EP4357347A1 (en) * 2021-06-21 2024-04-24 Henan Medinno Pharmaceutical Technology Co., Ltd. Trk kinase inhibitor compound and use thereof

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
GB9518953D0 (en) 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
TW438796B (en) 1996-05-15 2001-06-07 Hoffmann La Roche 2,4-diaminopyrimidine derivatives, the manufacture process thereof, and the antibiotically-active pharmaceutical composition containing the same
WO2000035296A1 (en) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Improved release of medicament active agents from a chewing gum coating
DE69815317T2 (de) * 1997-03-19 2005-04-07 Abbott Gmbh & Co. Kg Pyrrolo[2,3-d]pyrimidine und ihre verwendung als tyrosinkinase-inhibitoren
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
WO2001072751A1 (en) * 2000-03-29 2001-10-04 Knoll Gesellschaft Mit Beschraenkter Haftung Pyrrolopyrimidines as tyrosine kinase inhibitors
JP2003321472A (ja) 2002-02-26 2003-11-11 Takeda Chem Ind Ltd Ｇｒｋ阻害剤
GB0218168D0 (en) * 2002-08-06 2002-09-11 Astrazeneca Ab Compounds
UA80171C2 (en) 2002-12-19 2007-08-27 Pfizer Prod Inc Pyrrolopyrimidine derivatives
EP1706384A1 (en) 2004-01-07 2006-10-04 AstraZeneca AB Therapeutic agents i
US7417063B2 (en) 2004-04-13 2008-08-26 Bristol-Myers Squibb Company Bicyclic heterocycles useful as serine protease inhibitors
CA2566160C (en) * 2004-05-27 2011-01-18 Pfizer Products Inc. Pyrrolopyrimidine derivatives useful in cancer treatment
CA2608733A1 (en) * 2005-05-17 2007-02-01 Plexxikon, Inc. Pyrrol (2,3-b) pyridine derivatives protein kinase inhibitors
US7939556B2 (en) 2005-10-14 2011-05-10 Neurosearch A/S Imidazole derivatives and their use for modulating the GABAA receptor complex
GB0526044D0 (en) 2005-12-21 2006-02-01 Syngenta Ltd Novel herbicides
RU2323058C1 (ru) 2006-07-12 2008-04-27 ООО Научно-внедренческий центр "Машины и оборудование для энергетики" Способ формирования наружной резьбы на концевом участке трубной заготовки
PT2076508E (pt) 2006-10-18 2011-03-07 Pfizer Prod Inc Compostos de ureia de éter biarílico
MX2009006688A (es) 2006-12-21 2009-06-30 Plexxikon Inc Compuestos y metodos para modulacion de cinasas, e indicaciones para ello.
JP5361857B2 (ja) 2007-03-23 2013-12-04 ファイザー・リミテッド イオンチャネルの阻害剤
EA015952B1 (ru) 2007-05-03 2011-12-30 Пфайзер Лимитед 2-пиридинкарбоксамидные производные в качестве модуляторов натриевых каналов
US8124610B2 (en) 2007-07-13 2012-02-28 Icagen Inc. Sodium channel inhibitors
NZ582772A (en) 2007-07-17 2012-06-29 Plexxikon Inc Compounds and methods for kinase modulation, and indications therefor
PE20091846A1 (es) * 2008-05-19 2009-12-16 Plexxikon Inc DERIVADOS DE PIRROLO[2,3-d]-PIRIMIDINA COMO MODULADORES DE CINASAS
US8158636B2 (en) 2008-05-19 2012-04-17 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
WO2009152087A1 (en) 2008-06-10 2009-12-17 Plexxikon, Inc. Bicyclic heteroaryl compounds and methods for kinase modulation, and indications therefor
EP2313411A1 (en) 2008-06-10 2011-04-27 Plexxikon, Inc. 5h-pyrr0l0 [2,3-b]pyrazine derivatives for kinase modulation, and indications therefor
PL2385938T3 (pl) 2009-01-12 2015-07-31 Pfizer Ltd Pochodne sulfonamidu
KR101483215B1 (ko) * 2010-01-29 2015-01-16 한미약품 주식회사 단백질 키나아제 저해활성을 갖는 비시클릭 헤테로아릴 유도체
TWI619713B (zh) 2010-04-21 2018-04-01 普雷辛肯公司 用於激酶調節的化合物和方法及其適應症

Also Published As

Publication number Publication date
US20140364415A1 (en) 2014-12-11
CR20130470A (es) 2013-10-16
US8846698B2 (en) 2014-09-30
EP2694509B1 (en) 2016-05-18
SG193513A1 (en) 2013-10-30
CO6801740A2 (es) 2013-11-29
MX2013011612A (es) 2013-10-17
AP2013007159A0 (en) 2013-10-31
CL2013002821A1 (es) 2014-02-21
KR20130133905A (ko) 2013-12-09
IL228590A0 (en) 2013-12-31
TW201302757A (zh) 2013-01-16
WO2012137089A1 (en) 2012-10-11
US20120258950A1 (en) 2012-10-11
EP2694509A1 (en) 2014-02-12
AU2012238369A1 (en) 2013-10-03
CA2832291A1 (en) 2012-10-11
EA201391239A1 (ru) 2014-03-31
CA2832291C (en) 2015-12-01
ECSP13013009A (es) 2013-12-31
BR112013025792A2 (pt) 2018-04-24
CU20130129A7 (es) 2014-01-29
NI201300103A (es) 2014-02-12
PE20141050A1 (es) 2014-08-30
TWI443101B (zh) 2014-07-01
DOP2013000221A (es) 2014-03-16
GT201300236A (es) 2015-08-04
AR085852A1 (es) 2013-10-30
JP2014510131A (ja) 2014-04-24
JP5595616B2 (ja) 2014-09-24
NZ615557A (en) 2014-08-29
TN2013000394A1 (fr) 2015-01-20
CN103534257A (zh) 2014-01-22
ES2581848T3 (es) 2016-09-07
MA35024B1 (fr) 2014-04-03
GEP20156417B (en) 2015-12-25
UY34004A (es) 2012-11-30

Similar Documents

Publication Publication Date Title
UA108926C2 (ru) LibreOffice? [2,3-D] +" +" !+
MX2016006336A (es) Compuestos pirazolopirimidina.
MY165087A (en) Neprilysin inhibitors
UA109010C2 (en) MORPHOLINOPYRIMIDINES AND THEIR APPLICATIONS IN THERAPY
JO3115B1 (ar) مركبات بيريدازينون واستخدامها كمثبطات daao
PH12015500064B1 (en) Imidazotriazinecarbonitriles useful as kinase inhibitors
IN2014MN02598A (ru)
AU2012214029A8 (en) Rorgammat inhibitors
EA201600366A1 (ru) Производные бензимидазол-пролина
MY193277A (en) Certain amino-pyrimidines, compositions thereof, and methods for their use
UA111770C2 (uk) Інгібітори бромдомену
IN2015DN01119A (ru)
MX342212B (es) Inhibidores de neprilisina.
UA108640C2 (ru) Производные n-(имидазопиримидин 7-ил) гетероариламидов и их применение в качестве ингибиторов pde10a
EA024194B8 (ru) Содержащие диарилацетиленгидразид ингибиторы тирозинкиназы
IN2014CN04530A (ru)
UA117122C2 (uk) Хінолонові похідні
MX338551B (es) Nuevos compuestos de piridina fusionada como inhibidores de caseina quinasa.
MY186599A (en) Substituted pyridopyrazines as novel syk inhibitors
MX340233B (es) Agonistas de receptores de neurotrofina y sus usos como medicamentos.
PH12015501175A1 (en) Substituted pyridopyrazines as syk inhibitors
WO2014053968A8 (en) Pyrrolo[3,2-c]pyridine tropomyosin-related kinase inhibitors
EA201291014A1 (ru) Трициклическое индазольное соединение, способ его получения и содержащая его фармацевтическая композиция
EA201391586A1 (ru) ИНГИБИТОРЫ 17α-ГИДРОКСИЛАЗЫ/C-ЛИАЗЫ
UA109804C2 (xx) 2-метоксипіридин-4-ільні похідні